Abstract:
This article presents experimental data on the study of the possibility of early diagnosis of type 2 diabetes mellitus through the use of lipid-lowering therapy; statins are the drugs of choice. For the treatment of atherogenic dyslipidemia with high triglyceride levels and low concentration of high-density cholesterol (HDL-C), fibrates are traditionally used, including in patients with type 2 diabetes